Supernus Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Supernus Pharmaceuticals's total funding is $539.5M.
Employee Data
- Supernus Pharmaceuticals has 708 Employees.
- Supernus Pharmaceuticals grew their employee count by 9% last year.
Supernus Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP, Regulatory Affairs | Reveal Email/Phone |
2 | Executive Director, Sales Leadership Development & Inside Sales | Reveal Email/Phone |
3 | SVP Quality,GMP Operations & IT at Supernus Pharmaceuticals | Reveal Email/Phone |
4 | VP and Head Clinical Development | Reveal Email/Phone |
5 | VP, Biometrics | Reveal Email/Phone |
6 | VP Corporate Accounts | Reveal Email/Phone |
7 | VP - ADHD Division | Reveal Email/Phone |
8 | SVP, Supply Chain | Reveal Email/Phone |
9 | Head Program Management | Reveal Email/Phone |
10 | VP Pharmaceutical Sciences | Reveal Email/Phone |
Supernus Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7M | 35 | -3% | N/A | N/A |
#2 | $7.2M | 36 | -5% | N/A | N/A |
#3 | $10.5M | 52 | -9% | N/A | N/A |
#4 | $344.1M | 1712 | 9% | N/A | N/A |
#5 | $27.5M | 137 | 6% | N/A | N/A |
#6 | $107.3M | 534 | 9% | N/A | N/A |
#7 | $12.9M | 64 | 28% | N/A | N/A |
#8 | $31.6M | 157 | 1% | N/A | N/A |
#9 | $31.4M | 156 | 7% | N/A | N/A |
#10 | $11.5M | 57 | 30% | N/A | N/A |
What Is Supernus Pharmaceuticals?
Headquartered in Rockville, MD, Supernus Pharmaceuticals, Inc. (formerly Shire Laboratories) is a specialty pharmaceuticals company that has a broad portfolio of proven and patented drug delivery technologies. Among its key technologies are ProScreen® and OptiScreen® for lead selection and formulation optimization, Microtrol®, Solutrol® and EnSoTrol®, its oral controlled release technologies, and AvertSM, its reduced abuse potential technology. Supernus will focus on developing differentiated products for targeted specialty therapeutic areas on its own and in partnership with other pharmaceutical companies.
keywords:N/A
$539.5M
Total Funding
708
Number of Employees
N/A
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Supernus Pharmaceuticals News
Supernus Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of...
Supernus Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of...
Supernus Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of...
ROCKVILLE, Md., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Supernus’ proposed acquisition of Adamas Pharmaceuticals, Inc. ...
Other Companies in Rockville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $144.7M | 713 | 4% | N/A |
#2 | $292.7M | 721 | 0% | N/A |
#3 | $35M | 724 | N/A | N/A |
#4 | $35M | 757 | 9% | N/A |
#5 | $295.3M | 813 | 13% | N/A |